Taken daily, rarely considered: How antidepressants may increase the risk of heart problems.

A large Danish analysis suggests that certain groups of patients taking antidepressants die from sudden cardiac death far more often than others. Duration of treatment, age and severe mental illness all appear to matter. What does this mean for people in German-speaking countries - and should patients stop their tablets now?

What actually happens in sudden cardiac death

Sudden cardiac death may sound like something from a crime drama, but it describes an all-too-real medical emergency. The heart stops abruptly, circulation collapses, and the brain and lungs are no longer supplied with oxygen. Within seconds the person loses consciousness and breathing stops.

It can happen during sleep, while watching television or during exercise. It does not only affect older people with heart disease; it occurs across all age groups. In a country such as France, an estimated 60,000 people die this way each year - and the scale is similarly high in Germany.

In younger people, the cause is often an electrical disturbance of the heart rhythm or a thickened heart muscle. In later life, narrowed coronary arteries are the most common trigger. One striking pattern: people with mental health conditions appear disproportionately often in these figures across every age band.

"Patients with severe mental disorders have, on average, a markedly higher risk of sudden cardiac death - and antidepressants could contribute to part of that."

The Danish study: who was included?

Researchers in Denmark reviewed all adult deaths in the country in 2010 among people aged 18 to 90. They examined death certificates and post-mortem reports to identify cases of sudden cardiac death.

Alongside this, they analysed prescribing records. Anyone who had received at least two prescriptions for antidepressants within a single year at any point in the 12 years before 2010 was classed as “exposed”. From this, they created two groups:

• 1 to 5 years of treatment with antidepressants
  
• 6 years or longer of treatment with antidepressants

At the time, Denmark had around 4.3 million adults. Of these, just under 644,000 people had taken antidepressants. In 2010, 45,703 people died, including 6,002 from sudden cardiac death. Notably, 1,981 of these sudden deaths occurred in the antidepressant group.

How much does the risk rise - antidepressants and sudden cardiac death by age

When compared with people without an antidepressant prescription, a clear pattern emerged: in almost all age groups, sudden cardiac death occurred substantially more often among people taking antidepressants. The only exception was the 18–29 age group, where the association was not statistically clear.

After adjusting the data for age, sex and additional illnesses, the following approximate magnitudes were reported:

• 1–5 years of antidepressants: about a 56% higher risk of sudden cardiac death
  
• 6 years and longer: around a 2.2-fold increased risk
  

The situation looked particularly concerning in certain age bands:

Age	Duration of use	Risk factor vs general population
30–39 years	1–5 years	approx. 3-fold
30–39 years	≥ 6 years	approx. 5-fold
50–59 years	1–5 years	approx. 2-fold
50–59 years	≥ 6 years	approx. 4-fold
70–79 years	1–5 years	approx. 1.8-fold
70–79 years	≥ 6 years	approx. 2.2-fold

People with schizophrenia were at the top of the ranking: their risk of sudden cardiac death was about 4.5 times that of the general population.

Why the medicines are not simply “to blame”

Despite the headline figures, the researchers explicitly warned against jumping to simplistic conclusions. One reason is that severe depression and other psychiatric illnesses can themselves strain the cardiovascular system. Many affected people are less active, smoke more often, eat less healthily and seek medical help later. Each of these factors increases the likelihood of heart attacks and rhythm disturbances.

A second limitation: the study did not separate individual drugs. Modern selective serotonin reuptake inhibitors, older tricyclic antidepressants and MAO inhibitors were grouped together. In day-to-day practice, these classes can differ in how strongly they affect the heart and metabolism.

"The data show an association, but not a simple black-and-white question of blame: illness, lifestyle and medication interact."

How antidepressants can affect the heart

Even with those caveats, there are plausible medical reasons why part of the added risk could be linked directly to the medicines.

Electrical effects in the heart

Some antidepressants alter the electrical excitability of the heart muscle. On an ECG, this can appear as prolongation of the QT interval - the time during which the ventricles contract and then relax. A markedly prolonged QT interval can trigger dangerous rhythm disturbances, such as torsade de pointes tachycardias, which in the worst case can progress to ventricular fibrillation.

Weight, metabolism and blood vessels

Other preparations can promote weight gain and disrupt sugar and fat metabolism. This can lead to metabolic syndrome - a combination of excess weight, high blood pressure, raised blood lipids and impaired glucose regulation. This cluster is considered a strong risk factor for atherosclerosis of the coronary arteries and therefore for heart attacks and sudden cardiac death.

Should patients stop their tablets now?

The clear message from cardiology and psychiatry is: no - not without medical advice. Depression itself significantly increases cardiac risk, in some cases by around 60%. People who stop medication without clinical support often relapse into severe episodes, eat more poorly, move less and are less consistent with other treatments. That can ultimately raise overall risk rather than reduce it.

So the study is not a “stop” signal for antidepressants, but more of a warning light for clinicians and patients: move away from treating only symptoms “in the head”, and towards keeping the whole cardiovascular system in view.

• Never stop antidepressants on your own; always discuss changes with a clinician
  
• Plan regular cardiovascular checks (blood pressure, ECG, blood tests)
  
• Actively address weight, physical activity and smoking
  
• Seek medical help immediately for dizziness, fainting, palpitations or chest pain
  

What patients should discuss with their doctor in practical terms

Anyone who has been taking antidepressants for years can raise targeted questions at their next appointment. Useful topics include:

• Is there a family history of sudden cardiac death or early heart attacks?
  
• Have there ever been abnormal ECG findings, such as a prolonged QT interval?
  
• Is it possible to switch to a preparation with less effect on heart rhythm or weight?
  
• Are there other medicines involved that also prolong the QT interval?
  

Particularly with severe mental illness such as schizophrenia, closer coordination between psychiatry, a GP and cardiology can be sensible. Where the risk is highest, tighter monitoring is most worthwhile.

Why long-term therapy may be especially sensitive

The data suggest that very long durations of use are the main driver pushing risk upwards. That fits with the proposed biological mechanisms: weight gain, arterial calcification and persistent changes in the heart’s electrical system do not happen overnight - they build gradually.

This does not mean long-term treatment is generally wrong. Many people need medication for years to remain stable and to function at work and in relationships. What is sensible, though, is regular review: is the same dose still needed? Can psychotherapy, exercise therapy or other components be used more strongly to reduce the overall medication burden?

Heart and mind should sit in the same medical record

The analysis underlines how tightly mental and physical health are linked. Treating depression while ignoring the heart misses a key part of the picture. Conversely, any serious cardiac care should also pay attention to mental wellbeing - people who have had a heart attack often develop depression, which worsens prognosis.

For patients in German-speaking countries, this means antidepressants remain an important tool. At the same time, it is worth asking directly about personal cardiac risk at the next appointment - and agreeing a plan that protects mind and heart in equal measure.